Currently available bulk sequencing data do not necessarily support a model of neutral tumor evolution

Nat Genet. 2018 Dec;50(12):1620-1623. doi: 10.1038/s41588-018-0217-6.

Thomas O McDonald^#^{1

2

3

4}, Shaon Chakrabarti^#^{1

2

4}, Franziska Michor^{5

6

7

8}

¹ Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
² Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
³ Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA, USA.
⁴ Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
⁵ Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. [email protected].
⁶ Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA. [email protected].
⁷ Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA, USA. [email protected].
⁸ Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. [email protected].

^# Contributed equally.

No abstract available

Publication types